MetaGate: Interactive analysis of high-dimensional cytometry data with metadata integration.

data analysis diffuse large B-cell lymphoma flow cytometry mass cytometry

Journal

Patterns (New York, N.Y.)
ISSN: 2666-3899
Titre abrégé: Patterns (N Y)
Pays: United States
ID NLM: 101767765

Informations de publication

Date de publication:
12 Jul 2024
Historique:
received: 30 10 2023
revised: 12 03 2024
accepted: 15 04 2024
medline: 31 7 2024
pubmed: 31 7 2024
entrez: 31 7 2024
Statut: epublish

Résumé

Flow cytometry is a powerful technology for high-throughput protein quantification at the single-cell level. Technical advances have substantially increased data complexity, but novel bioinformatical tools often show limitations in statistical testing, data sharing, cross-experiment comparability, or clinical data integration. We developed MetaGate as a platform for interactive statistical analysis and visualization of manually gated high-dimensional cytometry data with integration of metadata. MetaGate provides a data reduction algorithm based on a combinatorial gating system that produces a small, portable, and standardized data file. This is subsequently used to produce figures and statistical analyses through a fast web-based user interface. We demonstrate the utility of MetaGate through a comprehensive mass cytometry analysis of peripheral blood immune cells from 28 patients with diffuse large B cell lymphoma along with 17 healthy controls. Through MetaGate analysis, our study identifies key immune cell population changes associated with disease progression.

Identifiants

pubmed: 39081571
doi: 10.1016/j.patter.2024.100989
pii: S2666-3899(24)00104-1
pmc: PMC11284499
doi:

Types de publication

Journal Article

Langues

eng

Pagination

100989

Informations de copyright

© 2024 The Authors.

Déclaration de conflit d'intérêts

K-J.M. is a consultant at Fate Therapeutics and Vycellix and has research support from Oncopeptides for studies unrelated to this work.

Auteurs

Eivind Heggernes Ask (EH)

Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.
The Precision Immunotherapy Alliance, University of Oslo, Oslo, Norway.

Astrid Tschan-Plessl (A)

Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.
Division of Hematology, University Hospital Basel, Basel, Switzerland.

Hanna Julie Hoel (HJ)

Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.

Arne Kolstad (A)

Department of Oncology, Innlandet Hospital Trust Division Gjøvik, Lillehammer, Norway.

Harald Holte (H)

Department of Oncology, Oslo University Hospital, Oslo, Norway.
K.G. Jebsen Centre for B Cell Malignancies, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.

Karl-Johan Malmberg (KJ)

Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.
The Precision Immunotherapy Alliance, University of Oslo, Oslo, Norway.
Center for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden.

Classifications MeSH